Original Articles

Antibiotic resistance patterns of co-isolated Escherichia coli and Klebsiella spp.: a cross-sectional study on their association with antibiotic usage intensity

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 9 March 2025
Accepted: 22 April 2025
Published: 16 May 2025
887
Views
534
Downloads

Authors

Antimicrobial Resistance (AMR) in Escherichia coli (E. coli) and Klebsiella spp. presents a growing public health concern, particularly in low-resource developing countries. However, data on their concurrent resistance patterns within the same host remain limited. This study aims to address this gap by evaluating the resistance profiles of co-isolated strains. In the context of this cross-sectional study E. coli and Klebsiella spp. were isolated from stool samples of 138 individuals attending Smart Health Tower, in Iraq. Samples were processed using standard microbiological protocols and identified through Gram staining and biochemical tests. Antibiotic susceptibility was tested using the Kirby-Bauer disk diffusion method. Participants were categorized into low, moderate, and high antibiotic users based on their antibiotic usage patterns. Statistical analysis was performed using SPSS, with significance set at p<0.05. Among E. coli isolates, multidrug resistance was significantly more prevalent in high antibiotic users, with 38/46 (82.6%) exhibiting resistance, compared to 17/46 (37.0%) in moderate antibiotic users and 2/46 (4.3%) in low antibiotic users (p < 0.001). For Klebsiella spp. isolates, multidrug resistance was found in 36/46 (78.3%) of high antibiotic users. Klebsiella spp. showed higher resistance to Ampicillin-Sulbactam (59.9%) compared to E. coli (40.0%). Additionally, resistance to Gentamicin was more pronounced in Klebsiella spp. (80.0%) than in E. coli (20.0%). This study emphasizes the need for stricter antimicrobial stewardship in high antibiotic-use settings. The high multidrug resistance in E. coli and especially Klebsiella spp., necessitates targeted interventions to curb resistance and preserve antimicrobial efficacy.

Downloads

Download data is not yet available.
World Health Organization. Antimicrobial resistance. Geneva: World Health Organization; 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 2015;109:309-18. DOI: https://doi.org/10.1179/2047773215Y.0000000030
Salam MA, Al-Amin MY, Salam MT, et al. antimicrobial resistance: a growing serious threat for global public health. Healthcare (Basel) 2023;11:1946 DOI: https://doi.org/10.3390/healthcare11131946
Shume T, Tesfa T, Mekonnen S, et al. Aerobic bacterial profile and their antibiotic susceptibility patterns of sterile body fluids among patients at Hiwot Fana specialized university hospital, Harar, eastern Ethiopia. Infect Drug Resist 2022:581-93. DOI: https://doi.org/10.2147/IDR.S351961
Al-Jumaili AA, Ahmed KK. A review of antibiotic misuse and bacterial resistance in Iraq. East Mediterr Health J 2024;30:663-70. DOI: https://doi.org/10.26719/2024.30.10.663.
Arafah AA. Antibiotic resistance trends among enterobacteriaceae in Saudi Arabia: A systematic review. Cureus 2024;16:e56614. DOI: https://doi.org/10.7759/cureus.56614
Ahmed SK, Hussein S, Qurbani K, et al. Antimicrobial resistance: impacts, challenges, and future prospects. J Med Surg Public Health 2024;2:100081. DOI: https://doi.org/10.1016/j.glmedi.2024.100081
Poku E, Cooper K, Cantrell A, et al. Systematic review of time lag between antibiotic use and rise of resistant pathogens among hospitalized adults in Europe. JAC Antimicrob Resist 2023;5:dlad001. DOI: https://doi.org/10.1093/jacamr/dlad001
Kagami K, Ishiguro N, Iwasaki S, et al. Correlation between antibiotic use and resistance of gram-negative bacteria at a university hospital in Japan from 2013 to 2021: a study using the Japan Surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) system. Eur J Hosp Pharm 2025;32:3-9. DOI: https://doi.org/10.1136/ejhpharm-2023-003797
World Health Organization. AWaRe classification of antibiotics for evaluation and monitoring of use, 2023. WHO Expert Committee on Selection and Use of Essential Medicines; 2023.
Weinstein MP, Lewis JS. The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. J Clin Microbiol 2020;58:10-128. DOI: https://doi.org/10.1128/JCM.01864-19
Polit DF, Beck CT. The content validity index: are you sure you know what's being reported? Critique and recommendations. Res Nurs Health 2006;29:489-97. DOI: https://doi.org/10.1002/nur.20147
Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81. DOI: https://doi.org/10.1111/j.1469-0691.2011.03570.x
Alvarez-Uria G, Gandra S, Mandal S, et al. Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae. Int J Infect Dis 2018;68:50-3. DOI: https://doi.org/10.1016/j.ijid.2018.01.011
Mączyńska B, Frej-Mądrzak M, Sarowska J, et al. Evolution of antibiotic resistance in Escherichia coli and Klebsiella pneumoniae clinical isolates in a multi-profile hospital over 5 years (2017–2021). J Clin Med 2023;12:2414. DOI: https://doi.org/10.3390/jcm12062414
Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharm Ther 2015;40:277.
Schröder W, Sommer H, Gladstone BP, et al. Gender differences in antibiotic prescribing in the community: a systematic review and meta-analysis. J Antimicrob Chemother 2016;71:1800-6. DOI: https://doi.org/10.1093/jac/dkw054
Kalungia AC, Burger J, Godman B, et al. Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia. Expert Rev Anti Infect Ther 2016;14:1215-23. DOI: https://doi.org/10.1080/14787210.2016.1227702
Gandra S, Barter DM, Laxminarayan R. Economic burden of antibiotic resistance: how much do we really know?. Clin Microbiol Infect 2014;20:973-80. DOI: https://doi.org/10.1111/1469-0691.12798
Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 2016;387:176-87. DOI: https://doi.org/10.1016/S0140-6736(15)00473-0
Pulcini C, Binda F, Lamkang AS, et al. Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach. Clin Microbiol Infect 2019;25:20-5. DOI: https://doi.org/10.1016/j.cmi.2018.03.033
Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control 2017;6:1-8. DOI: https://doi.org/10.1186/s13756-017-0208-x
Pouwels KB, Hopkins S, Llewelyn MJ, et al. Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelines. BMJ 2019;364:l440. DOI: https://doi.org/10.1136/bmj.l440
Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 2018;18:318-27. DOI: https://doi.org/10.1016/S1473-3099(17)30753-3
Kaye KS, Harris AD, Gold H, Carmeli Y. Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patients. Antimicrob Agents Chemother 2000;44:1004-9. DOI: https://doi.org/10.1128/AAC.44.4.1004-1009.2000
World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report: 2021. Geneva: World Health Organization; 2021.
Klein EY, Milkowska-Shibata M, Tseng KK, et al. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data. Lancet Infect Dis 2021;21:107-15. DOI: https://doi.org/10.1016/S1473-3099(20)30332-7
Cassini A, Högberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis 2019;19:56-66. DOI: https://doi.org/10.1016/S1473-3099(18)30605-4
Centers for Disease Control and Prevention. Doxycycline individual-level harms – antimicrobial resistance. Atlanta: CDC; 2024. Available from: https://www.cdc.gov/sti/media/pdfs/2024/05/Doxycycline-Individual-Level-Harms-Antimicrobial-Resistance.pdf
Aytaç Ö. Antibiotic resistance rates of Klebsiella pneumoniae strains isolated from urine cultures. Northwest Med J 2024;4:64-9. DOI: https://doi.org/10.54307/2024.NWMJ.108
Rennie RP, Duncan IB. Emergence of gentamicin-resistant Klebsiella in a general hospital. Antimicrob Agents Chemother 1977;11:179-84. DOI: https://doi.org/10.1128/AAC.11.2.179
Hamadalneel YB, Alamin MF, Attaalla AM, Attaallah A. A four-year trend of ceftriaxone resistance and associated risk factors among different clinical samples in Wad Medani, Sudan: a cross-sectional retrospective study. Cureus 2024;16:e64184. DOI: https://doi.org/10.7759/cureus.64184
Pan X, Zhou Z, Liu B, et al. A novel therapeutic concern: Antibiotic resistance genes in common chronic diseases. Front Microbiol 2022;13:1037389. DOI: https://doi.org/10.3389/fmicb.2022.1037389
Karungamye P, Rugaika A, Mtei K, Machunda R. Antibiotic resistance patterns of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from hospital wastewater. Applied Microbiol 2023;3:867-82. DOI: https://doi.org/10.3390/applmicrobiol3030060
JoSeph NM, Bhanupriya B, ShewaDe DG, et al. Relationship between antimicrobial consumption and the incidence of antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae isolates. J Clin Diagn Res 2015;9:DC08. DOI: https://doi.org/10.7860/JCDR/2015/11029.5537
Byarugaba DK, Osman TS, Sayyouh OM, et al. Genomic epidemiology of multidrug-resistant Escherichia coli and Klebsiella pneumoniae in Kenya, Uganda, and Jordan. Emerg Infect Dis 2024;30:S33. DOI: https://doi.org/10.3201/eid3014.240370
Moini AS, Soltani B, Ardakani AT, et al. Multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolated from patients in Kashan, Iran. undishapur J Microbiol. 2015;8:e27517. DOI: https://doi.org/10.5812/jjm.27517
Sharland MR, Pulcini C, Harbarth S, et al. Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe. Lancet Infect Dis 2018;18:18-20. DOI: https://doi.org/10.1016/S1473-3099(17)30724-7
Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis. PloS One 2017;12:e0189621. DOI: https://doi.org/10.1371/journal.pone.0189621

How to Cite



Antibiotic resistance patterns of co-isolated Escherichia coli and Klebsiella spp.: a cross-sectional study on their association with antibiotic usage intensity . (2025). Journal of Biological Research - Bollettino Della Società Italiana Di Biologia Sperimentale, 98(2). https://doi.org/10.4081/jbr.2025.13803